Neurological function, information-motivation-behavioral skills factors, and risk behaviors among HIV-positive alcohol users

AIDS and Behavior

Volumn 16, Issue 8, 2012, Pages 2297-2308

  Malow, Robert M ^a   Dévieux, Jessy G ^a   Stein, Judith A ^b   Rosenberg, Rhonda ^a   Lerner, Brenda G ^a   Attonito, Jennifer ^a   Villalba, Karina ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol use; Condom skills; HIV positive; IMB model; Neurological function

Indexed keywords

ADULT; AGE; ALCOHOLISM; ARTICLE; ATTITUDE TO HEALTH; COGNITIVE DEFECT; CONDOM; FACTORIAL ANALYSIS; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MOTIVATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; QUESTIONNAIRE; RISK REDUCTION; SOCIAL BEHAVIOR; SOCIAL SUPPORT; UTILIZATION REVIEW;

ADULT; AGE FACTORS; ALCOHOL-RELATED DISORDERS; COGNITION DISORDERS; CONDOMS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; MOTIVATION; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; RISK-TAKING; SOCIAL BEHAVIOR; SOCIAL SUPPORT;

EID: 84868568470     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0246-6     Document Type: Article

References (75)

1. Fisher J, Fisher W. Changing AIDS-risk behavior. Psychol Bull. 1992;111:455-74.
2. Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of AIDSpreventive behavior with gay men and heterosexual university students. Health Psychol. 1994;13:238-50.
3. Malow RM, Stein JA, McMahon RC, Dévieux JG, Rosenberg R, Jean-Gilles M. Effects of a culturally adapted HIV prevention intervention in Haitian youth. J Assoc Nurses AIDS Care. 2009;20(2):110-21.
4. Kalichman S, Malow R, Devieux J, Stein JA, Piedman F. HIV risk reduction for substance using seriously mentally ill adults: test of the information-motivation-behavior skills (IMB) model. Commun Ment Health J. 2005;41(3):277-89.
5. Kalichman SC, Picciano JF, Roffman RA. Motivation to reduce HIV risk behaviors in the context of the information, motivation and behavioral skills (IMB) model of HIV prevention. J Health Psychol. 2008;13(5):680-9.
6. Bryan A, Fisher J, Fisher W, Murray D. Understanding condom use among heroin addicts in methadone maintenance using the information-motivation- behavioral skills model. Subs Abuse Misuse. 2000;35(1):451-47.
7. Kalichman S, Stein J, Malow R, Averhart C, Dévieux J, Jennings T, et al. Predicting protected sexual behaviour using the information- motivation-behaviour skills model among adolescent substance abusers in court-ordered treatment. Psychol Health Med. 2002;7(3):327-39.
8. Norman LR, Basso M, Kumar A, Malow R. Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2009;2(2):143-56.
9. Durvasula R, Norman L, Malow R. Current perspectives on the neuropsychology of HIV. In: Pope C, White R, Malow R, editors. HIV/AIDS: global frontiers in prevention/intervention. New York: Routledge; 2009. p. 177-90.
10. Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M, et al. Updated research nosology for HIV associated neurocognitive disorders. Neurology. 2007;69:1789-99.
11. del Palacio M, A ́ lvarez S, Muñoz-Fernández MÁ . HIV-1 infection and neurocognitive impairment in the current era. Rev Med Virol. 2011;85(21):11468-78.
12. Gandhi NS, Skolasky RL, Peters KB, Moxley RT 4th, Creighton J, Roosa HV, Selnes OA, McArthur J, Sacktor N. A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J Neurovirol. 2011;17:159-65.
13. Foley JM, Wright MJ, Gooding AL, Ettenhofer M, Kim M, Choi M, Castellon SA, Sadek J, Heaton RK, van Gorp WG, Marcotte TD, Hinkin CH. Operationalization of the updated diagnostic alogarithm for classifying HIV-related cognitive impairment and dementia. Int Psychogeriatr. 2011;23(5):835-43.
14. Gisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011;11:356.
15. Sacktor N. The epidemiology of human immunodeficiency virusassociated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002;8(2):115-21.
16. Lopez OL, Smith G, Meltzer CC, Becker JT. Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12(3):184-92.
17. Woods S, Moore D, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152-68.
18. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retrovir. 2004;20(2): 151-5.
19. Conigliaro J, Justice AC, Gordon AJ, Bryant K, VACS Alcohol and Behavior Change Research Group. Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: a conceptual model to guide the implementation of evidence-based interventions into practice. Med Care. 2006;44(8 Supl. 2):S1-S6.
20. Farinpour R, Martin EM, Seidenberg M, Pitrak DL, Pursell KJ, Mullane KM, Novak RM, Harrow M. Verbal working memory in HIV-seropositive drug users. J Int Neuropsychol Soc. 2000;6: 548-55.
21. Martin EM, Pitrak DL, Weddington W, Rains NA, Nunnally G, Nixon H, Grbesic S, Vassileva J, Bechara A. Cognitive impulsivity and HIV serostatus in substance dependent males. J Int Neuropsychol Soc. 2004;10(7):931-8.
22. Rothlind JC, Greenfield TM, Bruce AV, Meyerhoff DJ, Flenniken DL, Lindgren JA, Weiner MW. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc. 2005;11(1):70-83.
23. Centers for Disease Control and Prevention. Establishing a holistic framework to reduce inequities in HIV, viral hepatitis, STDS, and tuberculosis in the United States. Atlanta: Department of Health and Human Services; 2010.
24. Koopman C, Gore-Felton C, Marouf F, Butler LD, Field N, Gill M, Chen XH, Israelski D, Spiegel D. Relationships of perceived stress to coping, attachment and social support among HIV-positive persons. AIDS Care. 2000;12(5):663-72.
25. Reif S, Mugavero M, Raper J, Thielman N, Leserman J, Whetten K, Pence BW. Highly stressed: stressful and traumatic experiences among individuals with HIV/AIDS in the Deep South. AIDS Care. 2011;23(2):152-62.
26. McMahon RC, Penedo FJ, Loewinger L, Jennings TE. Stress, social support and HIV risk among drug dependent men. Am Psychol. 1998;53(8):882-939.
27. Pence BW, Raper JL, Reif S, Thielman NM, Leserman J, Mugavero MJ. Incident stressful and traumatic life events and human immunodeficiency virus sexual transmission risk behaviors in a longitudinal, multisite cohort study. Psychosom Med. 2010;72(7):720-6.
28. Miller GE, Cole SW. Social relationships and the progression of human immunodeficiency virus infection: a review of evidence and possible underlying mechanisms. Ann Behav Med. 1998;20 (3):181-9.
29. Adib SM, Joseph JG, Ostrow DG, James SA. Predictors of relapse in sexual practices among homosexual men. AIDS Educ Prev. 1991;3:293-304.
30. Kimberly JA, Serovich JM. The role of family and friend social support in reducing risk behaviors among HIV-positive gay men. AIDS Educ Prev. 1999;11(6):465-75.
31. St. Lawrence JS, Brasfield TL, Jefferson KW, Allyene E, Shirley A. Social support as a factor in African-American adolescents' sexual risk behavior. J Adolesc Res. 1994;9(3):292-10.
32. McMahon RC, Malow RM, Jennings TE. Personality, stress, and social support in HIV risk prediction. AIDS Behav. 2000;4(4): 399-410.
33. D'Elia L, Satz P, Uchiyama C, White T. Color Trails Test. Odessa: Psychological Assessment Resources; 1996.
34. Tombaugh T. Trail making test A and B: normative data stratified by age and education. Archiv Clin Neuropsychol. 2004;19: 203-14.
35. Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, et al. WHO neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994;51(1):51-61.
36. Bornstein R. Normative data on selected neuropsychological measures from a nonclinical sample. J Clin Psychol. 1985;41(5): 651-9.
37. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the life experiences survey. J Consult Clin Psychol. 1978;46:932-46.
38. Yuan KH, Bentler PM, Kano Y. On averaging variables in a confirmatory factor analysis model. Behaviormetrika. 1997;24: 71-83.
39. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705-14.
40. Jaworski BC, Carey MP. Development and psychometric evaluation of a self-administered questionnaire to measure knowledge of sexually transmitted diseases. AIDS Behav. 2007;11:557-74.
41. DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34:11-25.
42. Brien TM, Thombs DL, Mahoney CA, Wallnau L. Dimensions of self-efficacy among three distinct groups of condom users. J Am Coll Health. 1994;42:167-74.
43. Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39:219-25.
44. Malow R, Dévieux JG, Rosenberg R, Capp L, Schneiderman N. A cognitive-behavioral intervention for HIV+ recovering drug abusers: the 2000-2005 NIDA-funded AIDS prevention center study. Psychol AIDS Exch. 2001;30:23-6.
45. Sorensen JL, London J, Morales E. Group counseling to prevent AIDS. In: Sorensen J, Wermuth L, Gibson D, Choi K, Guydish J, Batki S, editors. Preventing AIDS in drug users and their sexual partners. New York: Guilford; 1991. p. 99-115.
46. National Institute on Drug Abuse (NIDA). NIDA risk behavior assessment. Rockville: NIDA; 1991.
47. Carey MP, Carey KB, Maisto SA, Gordon CM, Weinhardt LS. Assessing sexual risk behaviour with the timeline followback (TLFB) approach: continued development and psychometric evaluation with psychiatric outpatients. Int J STD AIDS. 2001;12:365-75.
48. Weinhardt LS, Carey MP, Maisto SA, Carey KB, Cohen MM, Wickramasinghe SM. Reliability of the timeline followback sexual behavior interview. Ann Behav Med. 1998;20:25-30.
49. Weinhardt LS, Otto-Salaj LL, Brondino MJ, Norberg MM, Kalichman S. Sex-related alcohol expectancies predict sexual risk behavior among severely and persistently mentally ill adults. Psychol Addict Behav. 2002;16:64-7.
50. Bentler PM. EQS structural equations program manual. Encino: Multivariate Software; 2006.
51. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6:1-55.
52. Chou CP, Bentler PM. Model modification in covariance structure modeling: a comparison among likelihood ratio, Lagrange Multiplier, and Wald tests. Multivar Behav Res. 1990;25:115-36.
53. MacCallum RC. Specification searches in covariance structure modeling. Psychol Bull. 1986;100:107-20.
54. Mothobi NZ, Brew BJ. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis. 2011; 24(5):503-8.
55. Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ. Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol. 2010;16(2):101-14.
56. Robinson-Papp J, Elliott KJ, Simpson DM. HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep. 2009;6(3):146-52.
57. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3-16.
58. Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin JJ, et al. Antiretroviral medications disrupt microglial phagocytosis of bamyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain. 2011;4:23.
59. Cysique LA, Waters EK, Brew BJ. Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. BMC Neurol. 2011;11:148.
60. Dévieux J, Malow R, Stein JA, Jennings TE, Lucenko BA, Averhart C, et al. Impulsivity and HIV risk among adjudicated alcohol and other drug-abusing adolescent offenders. AIDS Educ Prevent. 2002;14(Supplement B):24-3.
61. Martin EM, Sullivan TS, Reed RA, Fletcher TA, Pitrak DL, Weddington W, Harrow M. Auditory working memory in HIV-1 infection. J Int Neuropsychol Soc. 2001;7(1):20-6.
62. Courtney KE, Arellano R, Barkley-Levenson E, Gálvan A, Poldrack RA, Mackillop J, David Jentsch J, Ray LA. The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcohol Clin Experim Res. 2011. doi:10.1111/j.1530-0277.2011.01635.x.
63. MacDonald TK, Zanna MP, Fong GT. Why common sense goes out the window: Effects of alcohol on intentions to use condoms. Personal Soc Psychol Bull. 1996;22:763-75.
64. Carey K, Scott-Sheldon L, Carey M, Cain D, Mlobeli R, Vermaak R, et al. Community norms for HIV risk behaviors among men in a South African township. J Behav Med. 2011;34(1): 32-40.
65. Catania JA, Coates TJ, Stall R. Changes in condom use among homosexual men in San Francisco. Health Psychol. 1991;10: 190-9.
66. Sobo EJ. Finance, romance, social support, and condoms: use among impoverished inner-city women. Hum Organ. 1995;54:115-28.
67. Cohen S, Wills TA. Stress, social support and the buffering hypothesis. Psychol Bull. 1985;98:310-57.
68. Malow RM, Gustman S, Ziskind D, McMahon R, Lawence J. Evaluating HIV prevention interventions among drug abusers: validity issues. J HIV/AIDS Prevent Educ Adolesc Child. 1998;2:21-40.
69. Schroder K, Carey MP, Vanable P. Methodological challenges in research on sexual risk behavior: I accuracy of self-reports. Ann Behav Med. 2003;26:104-23.
70. Huy NV, Dunne MP, Debattista J, Hien NT, An DTM. Association of human immunodeficiency virus (HIV) preventive information, motivation, self-efficacy and depression with sexual risk behaviors among male freelance laborers. J AIDS HIV Res. 2011;3(1):20-9.
71. Blume A, Davis J, Schmaling K. Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change. J Psychoact Drugs. 1999;31(2):111-5.
72. Morgenstern J, Bates ME. Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment. J Stud Alcohol. 1999;60(6):846-55.
73. Blume AW, Marlatt GA. The role of executive cognitive functions in changing substance use: what we know and what we need to know. Ann Behav Med. 2009;37(2):117-25.
74. Calsyn D, Hatch-Maillette M, Tross S, Doyle S, Crits-Christoph P, Song Y, et al. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. J Subst Abuse Treat. 2009;37(2):138-50.
75. Anand P, Springer S, Copenhaver M, Altice F. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14(6):1213-26.